Technology

Fusion reactor developer Helical Fusion raises $20m in Series B second close

Fusion reactor developer Helical Fusion closed the second tranche of its Series B at ¥3.23bn ($20m), adding Fuji Electric, Fujikura and Tokyo Gas as investors.
2026.10.12
Technology
Series

Vol. 28 | Honen and Shinran: Master and Disciple

How did Shinran become Honen's disciple, and why do the sources say so little about their time together? Vol. 28 traces the master–disciple bond up to the 1207 exiles.
2026.10.09
SeriesThe Jodo Ethic and the Spirit of the Ohmi Shonin
Series

Vol. 27 | The Precepts in Japanese Buddhism, Seen Through the Shinran Muki

Shinran's dream of Guze Kannon promised salvation even if he broke the precept against sex. What does it reveal about Buddhist precepts, Akunin Shoki and modern excess?
2026.10.06
SeriesThe Jodo Ethic and the Spirit of the Ohmi Shonin
Technology

Picosecond laser developer Spectronix raises $3.3m in Series F extension round

Osaka-based Spectronix has raised ¥518m ($3.3m) in a Series F extension to scale mass production of its picosecond DUV laser oscillators.
2026.10.05
Technology
Business

Don Quijote operator PPIH to acquire Toys”R”Us-Japan business

PPIH, the Don Quijote operator, signed a sponsor agreement with Toys"R"Us-Japan, which filed for civil rehabilitation. Why the deal echoes its Nagasakiya buy.
2026.10.02
Business
Technology

QibiTech, developer of multi-vendor robot control software, raises $3.8m in Series B

QibiTech, developer of the multi-vendor robot control software HATS, has raised around ¥600m ($3.8m) in a Series B round to expand development and sales.
2026.09.30
Technology
Technology

Autonomous robot developer LOMBY raises $2.4m in Series A

Robotics startup LOMBY raised ¥387m ($2.4m) in Series A to mass-produce LM-A, a low-speed delivery robot trialled with Seven-Eleven in Hachioji.
2026.09.29
Technology
Series

Vol. 26 | How the Future Founders of Jodo Shu and Jodo Shinshu Met

How Shinran, a minor noble's son ordained at nine, left Mount Hiei and, after a dream at Rokkakudo, became the disciple of Honen.
2026.09.28
SeriesThe Jodo Ethic and the Spirit of the Ohmi Shonin
Technology

Metagen Therapeutics, developer of ulcerative colitis drugs, raises $1.9m in second close of Series B extension

Tsuruoka-based Metagen Therapeutics has raised $1.9m from GLIN Impact Capital in its Series B extension, backing clinical development of its oral FMT drug for ulcerative colitis.
2026.09.25
Technology
Series

Vol. 25 | The Thought of Honen

Honen broke from Mount Hiei to found Jodo Shu, arguing that in the age of Mappo, recitative nembutsu — not deathbed rites — was the path to rebirth in the Pure Land.
2026.09.22
SeriesThe Jodo Ethic and the Spirit of the Ohmi Shonin
Next
Copied title and URL